International Biotechnology (UK) Buy Hold or Sell Recommendation
| IBT Stock | 650.00 6.00 0.93% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding International Biotechnology Trust is 'Hold'. Macroaxis provides International Biotechnology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IBT positions.
Check out International Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as International and provide practical buy, sell, or hold advice based on investors' constraints. International Biotechnology Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
International |
Execute International Biotechnology Buy or Sell Advice
The International recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on International Biotechnology Trust. Macroaxis does not own or have any residual interests in International Biotechnology Trust or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute International Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
International Biotechnology Trading Alerts and Improvement Suggestions
| International Biotechnology generated a negative expected return over the last 90 days | |
| International Biotechnology is unlikely to experience financial distress in the next 2 years | |
| Latest headline from news.google.com: Insider Buying International Biotechnology Insider Buys 6,996 Shares of Stock - MarketBeat |
International Biotechnology Returns Distribution Density
The distribution of International Biotechnology's historical returns is an attempt to chart the uncertainty of International Biotechnology's future price movements. The chart of the probability distribution of International Biotechnology daily returns describes the distribution of returns around its average expected value. We use International Biotechnology Trust price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of International Biotechnology returns is essential to provide solid investment advice for International Biotechnology.
| Mean Return | -0.08 | Value At Risk | -2.66 | Potential Upside | 1.48 | Standard Deviation | 1.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of International Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
International Biotechnology Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 23.6M | (3.5M) | (10.0M) | (16.2M) | (18.6M) | (17.7M) | |
| Change In Cash | (2.5M) | (19.7M) | 7.5M | 42.9M | 49.3M | 51.8M | |
| Free Cash Flow | (14.5M) | 1.1M | 27.3M | 45.4M | 52.2M | 54.8M | |
| Change In Working Capital | (42.4M) | 228K | 22.1M | (732K) | (841.8K) | (883.9K) | |
| Begin Period Cash Flow | (17.8M) | (20.3M) | (40.0M) | (32.5M) | (29.2M) | (27.8M) | |
| Other Cashflows From Financing Activities | 441K | 23.6M | (3.5M) | (10.0M) | (11.5M) | (10.9M) | |
| Other Non Cash Items | (162K) | 23.2M | (1.7M) | 7.2M | 8.3M | 8.7M | |
| Total Cash From Operating Activities | (14.5M) | 1.1M | 27.3M | 45.4M | 52.2M | 54.8M | |
| Net Income | 28.0M | (22.3M) | 6.9M | 38.9M | 35.0M | 20.4M | |
| Total Cash From Financing Activities | 12.0M | (16.4M) | (21.4M) | (2.2M) | (2.5M) | (2.7M) | |
| End Period Cash Flow | (20.3M) | (40.0M) | (32.5M) | 10.4M | 9.4M | 9.9M | |
| Change To Account Receivables | (781K) | (33K) | (25K) | 14K | 12.6K | 12.0K | |
| Dividends Paid | 11.6M | 12.9M | 11.4M | 10.8M | 12.4M | 11.1M | |
| Change To Operating Activities | 25.7M | (64.9M) | (43.1M) | 19.0M | 21.9M | 23.0M | |
| Change To Liabilities | 913K | (568K) | 1.5M | 261K | 234.9K | 152.6K |
International Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to International Biotechnology or Capital Markets sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that International Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a International stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 0.44 | |
σ | Overall volatility | 1.19 | |
Ir | Information ratio | 0.02 |
International Biotechnology Volatility Alert
International Biotechnology Trust exhibits very low volatility with skewness of -0.48 and kurtosis of 0.68. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure International Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact International Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.International Biotechnology Fundamentals Vs Peers
Comparing International Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze International Biotechnology's direct or indirect competition across all of the common fundamentals between International Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as International Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of International Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing International Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare International Biotechnology to competition |
| Fundamentals | International Biotechnology | Peer Average |
| Return On Equity | 0.14 | -0.31 |
| Return On Asset | 0.0806 | -0.14 |
| Profit Margin | 0.91 % | (1.27) % |
| Operating Margin | 1.00 % | (5.51) % |
| Current Valuation | 247.12 M | 16.62 B |
| Shares Outstanding | 35.45 M | 571.82 M |
| Shares Owned By Insiders | 1.42 % | 10.09 % |
| Shares Owned By Institutions | 27.15 % | 39.21 % |
| Price To Book | 0.82 X | 9.51 X |
| Price To Sales | 6.18 X | 11.42 X |
| Revenue | 40.14 M | 9.43 B |
| Gross Profit | 42.88 M | 27.38 B |
| EBITDA | 39.55 M | 3.9 B |
| Net Income | 38.88 M | 570.98 M |
| Total Debt | 22.83 M | 5.32 B |
| Book Value Per Share | 7.66 X | 1.93 K |
| Cash Flow From Operations | 45.35 M | 971.22 M |
| Earnings Per Share | 1.02 X | 3.12 X |
| Beta | 0.18 | -0.15 |
| Market Capitalization | 230.45 M | 19.03 B |
| Total Asset | 308.15 M | 29.47 B |
| Retained Earnings | (54.03 M) | 9.33 B |
| Annual Yield | 0.05 % | |
| Net Asset | 308.15 M | |
| Last Dividend Paid | 0.28 |
International Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as International . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About International Biotechnology Buy or Sell Advice
When is the right time to buy or sell International Biotechnology Trust? Buying financial instruments such as International Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having International Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in International Stock
International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.